Evaluating HIV vaccines using nonhuman primates
Simian Vaccine Evaluation Unit: Core Activities - Administrative and Technical Support
This study is working on creating effective HIV vaccines using nonhuman primates to see how well they can help the immune system fight off the virus, with the goal of finding a vaccine that can prevent or control HIV infection.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10817648 on NIH RePORTER |
What this research studies
This research focuses on the development and evaluation of effective HIV vaccines through the use of nonhuman primates (NHPs) in preclinical studies. The Simian Vaccine Evaluation Units (SVEUs) provide essential resources for researchers to assess candidate AIDS vaccines, allowing for thorough evaluations of immune responses and vaccine efficacy. By conducting these evaluations, the research aims to identify vaccines that can generate immune responses capable of preventing or controlling HIV infection. The program supports all stages of AIDS vaccine research, from initial testing to clinical evaluation.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals at high risk for HIV infection who may eventually receive effective vaccines developed through these studies.
Not a fit: Patients who are already living with HIV or those who do not have access to vaccine programs may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that prevent HIV infection, significantly improving public health outcomes.
How similar studies have performed: Previous research using nonhuman primates for HIV vaccine evaluation has shown promise, indicating that this approach has the potential for success.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Aye, Pyone — Tulane University of Louisiana
- Study coordinator: Aye, Pyone
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.